As the international community grapples with the lingering trauma of the COVID-19 pandemic, a transformative shift is occurring in global health governance. At the United Nations High-Level Meeting (UN HLM) in New York in September 2026, the focus shifted from crisis management to the formalization of a new legal architecture: the Political Declaration on Pandemic Prevention, Preparedness, and Response (PPPR). Central to this evolution is the World Health Organization’s (WHO) Pandemic Agreement (PA), a landmark instrument that seeks to reconcile the competing demands of national sovereignty and collective global security. India, positioned at the intersection of the Global North’s technological ambitions and the Global South’s development imperatives, has emerged as a pivotal architect in these negotiations.
The Genesis of a Global Legal Regime
The Pandemic Agreement, adopted by 124 member states in 2025, represents the first significant attempt to create a binding international framework for managing future biological threats. While no nation cast a dissenting vote, the 11 abstentions during the adoption process signaled the fragility of the consensus. The negotiations were characterized by a deep-seated tension: how to enforce global health standards without infringing upon the sovereign rights of individual nations.
The dialogue was polarized along the classic divide between the Global North and the Global South. Developing nations, many with fragile health systems, argued that “One Health” mandates—which require stringent monitoring of the human-animal-environment interface—are impossible to implement without guaranteed, sustained financial support. Conversely, wealthier nations remained wary of binding technology-transfer agreements, fearing that mandates to share vaccines in real-time at affordable prices would undermine the intellectual property protections of their private pharmaceutical giants.
Chronology of the Pandemic Agreement
- 2023: During its G-20 Presidency, India launches the Global Initiative for Digital Health, setting the stage for its advocacy for digital public infrastructure as a global good.
- 2025: The WHO Pandemic Agreement is formally adopted by 124 member states, establishing a framework for global collaboration while highlighting deep divides over resource sharing.
- September 2026: At the UN HLM, India delivers official remarks on the PPPR, emphasizing the need for equitable access to therapeutics and respect for national sovereignty.
- Late 2026: Launch of the “Partners for Multilateralism” initiative, involving a diverse group of nations, including India, Australia, and Brazil, to harmonize global policy.
- Late 2027 (Anticipated): The United Kingdom’s G-20 leadership will host the H20 summit, where pandemic preparedness remains a core agenda item, providing a platform for India to steer the next phase of implementation.
The PABS Bottleneck: The Pathogen Access and Benefit-Sharing System
Despite the adoption of the PA, the agreement remains in a state of suspended animation, awaiting finalization of its most critical annex: the Pathogen Access and Benefit-Sharing (PABS) system. The PABS is designed to be the "quid pro quo" of the treaty. It mandates that when countries share data or samples of emerging pathogens, they must receive a guaranteed, equitable portion of the resulting vaccines, diagnostics, and therapeutics.
For the Global South, the PABS is not merely a technical detail; it is a matter of survival. During the COVID-19 pandemic, many developing nations were left at the back of the queue, relying on charity rather than guaranteed access. Without a functional PABS, the Pandemic Agreement risks becoming a hollow document that protects the health of the affluent while leaving the rest of the world vulnerable. India, as a leading negotiator, is currently at the center of these discussions, pushing for a mechanism that ensures the “pharmacy of the world” can access the technologies necessary to manufacture life-saving products during a crisis.
Official Responses and Strategic Positioning
India’s stance at the 2026 UN HLM was marked by a sophisticated balancing act. While acknowledging the necessity of a multilateral framework, New Delhi successfully enshrined the principle of national sovereignty within the PPPR. The Indian delegation argued that international coordination is not a substitute for national policy but a supplement to it.
The Contrast in Global Leadership
The divergence in perspectives was best exemplified by the United States’ rejection of the Declaration. The U.S. administration expressed concerns that the PABS mechanism and the expanded role of the WHO in declaring pandemics could infringe upon its national decision-making capacity. In contrast, India chose a middle path, advocating for a “sovereignty-first” approach that does not abandon multilateralism. By positioning itself as a bridge-builder, India has sought to appease the Global North’s desire for efficiency while championing the Global South’s demand for equity.
Implications for Global Health Governance
The effectiveness of the PA will ultimately depend on whether it can overcome the systemic inequities exposed by the COVID-19 pandemic. For India, the implications are three-fold:
1. Strengthening South-South Cooperation
India must leverage its influence to lead the Global South in the post-PABS era. By developing partnerships focused on the technical aspects of the PA—such as surveillance, health workforce training, and One Health implementation—India can build trust and establish a repository of operational solutions.
2. Utilizing Political Platforms
India’s involvement in the H20 summit and the “Partners for Multilateralism” coalition provides a strategic venue to advocate for its priorities. As a key player in the European Union-backed multilateralism initiative, India can ensure that the voice of the Global South is not drowned out by the technological hegemony of the North.
3. Domestic Alignment as a Prerequisite for Leadership
India’s global influence is inextricably linked to its domestic policy. To command respect on the international stage, India must ensure its internal regulatory architecture—specifically regarding the access to biological material and the distribution of medical benefits—meets the highest global standards of equity. If India can demonstrate a robust, transparent domestic system, it gains the moral and political capital to demand the same from its global partners.
The "Pharmacy of the World" Dilemma
India occupies a unique position in the global health landscape. It manufactures a significant volume of the world’s vaccines, yet it remains heavily reliant on imported Active Pharmaceutical Ingredients (APIs) and foreign-held patents for cutting-edge medical technology.
An equitable global regime is therefore a strategic necessity for India. To move beyond being a mere manufacturing hub, India needs access to the latest technology from the Global North to strengthen its own medical device and high-grade PPE production. By advocating for an agreement that mandates technology transfer, India is not just asking for aid; it is fostering a sustainable ecosystem that benefits the entire world.
Conclusion: A Vision for Inclusive Governance
The Pandemic Agreement is a testament to the fact that, in a globalized world, health is the ultimate collective good. The challenge remains to operationalize this recognition in a way that respects the autonomy of nations while ensuring the safety of the human race.
India’s proactive engagement in the PA signifies a maturation of its role as a global power. By emphasizing that "Global Solidarity must be demonstrated through action," India is setting a high bar for international cooperation. As the world moves toward the finalization of the PABS annex and the broader implementation of the PPPR, the world will look to India not only as a producer of vaccines but as a leader capable of crafting a more equitable and inclusive future for global health. Whether the Pandemic Agreement will truly prevent the inequities of the past or merely institutionalize them depends largely on the success of this delicate, ongoing diplomatic dance.
